Elevated Levels of Soluble CD147 are Associated with Hyperinflammation and Disease Severity in COVID-19: A Proof-of-Concept Clinical Study (Q113906419)
Jump to navigation
Jump to search
scientific article published in 2022
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Elevated Levels of Soluble CD147 are Associated with Hyperinflammation and Disease Severity in COVID-19: A Proof-of-Concept Clinical Study |
scientific article published in 2022 |
Statements
Elevated Levels of Soluble CD147 are Associated with Hyperinflammation and Disease Severity in COVID-19: A Proof-of-Concept Clinical Study (English)
1 reference
1 reference
Rashidi Springall
1 reference
Julieta González-Flores
1 reference
Carlos García-Ávila
1 reference
Yaneli Juárez-Vicuña
1 reference
Adrián Hernández-Diazcouder
1 reference
Ricardo Márquez-Velasco
1 reference
Sergio Cásares-Alvarado
1 reference
Fausto Sánchez-Muñoz
1 reference
Edna Basilio-Gálvez
1 reference
Mauricio Castillo-Salazar
1 reference
Martha A. Ballinas-Verdugo
1 reference
Malinalli Brianza-Padilla
1 reference
José L. Sánchez-Gloria
1 reference
Claudia Tavera-Alonso
1 reference
Julio Sandoval
1 reference
Héctor González-Pacheco
1 reference
3 August 2022
1 reference
70
1 reference
1
1 reference